Multiplexed lateral flow assay integrated with orthogonal CRISPR-Cas system for SARS-CoV-2 detection

Gaoxing Su1, Min Zhu1, Diyuan Li1

  • 1School of Pharmacy, Nantong University, Nantong, Jiangsu 226001, China.

Sensors and Actuators. B, Chemical
|August 29, 2022
PubMed
Summary

A novel orthogonal CRISPR-Cas multiplexed lateral flow assay (OC-MLFA) enables sensitive and accurate SARS-CoV-2 detection. This field-deployable platform offers reliable point-of-care testing for infectious diseases.

Related Concept Videos